The river prawn, a natural predator of parasite-carrying snails, is effective at curbing the spread of schistosomiasis in West Africa, according to new research.
A study in Senegal, West Africa, finds that freshwater prawns can serve as an effective natural solution in the battle against schistosomiasis, a potentially deadly parasitic disease that infects about 230 million people.
“They are delicious”
The prawns prey on parasite-infected snails, while providing a source of marketable protein-rich food. Because prawns cannot support schistosomiasis’ complex life cycle, they do not transmit the disease themselves.
“The results of our study open the pathway to a novel approach for the control of schistosomiasis,” says coauthor Giulio De Leo, a biology professor at Stanford University’s Hopkins Marine Station and a senior fellow at the Stanford Woods Institute for the Environment.
Fewer infected snails
The study, published in the Proceedings of the National Academy of Sciences, tracked parasite-infected snails and people in two villages. In one village, the research team and Senegalese partner Biomedical Research Center Espoir pour la Santé stocked a river access point with prawns.
Over the course of 18 months, they found 80 percent fewer infected snails and a 50 percent lower disease burden (the mean number of parasite eggs in a person’s urine) in people living in the prawn-stocked village.
In a mathematical model of the system, stocking prawns, coupled with infrequent mass drug treatment, eliminated schistosomiasis in high-transmission sites. “Where drugs, alone, fail to control schistosomiasis due to rapid reinfection, prawns may offer a complementary strategy” for controlling the disease, the study’s authors write.
Local communities could be incentivized to maintain prawn populations in order to market them as a food product, the researchers note.
“They are delicious,” says lead author Susanne Sokolow, a Woods-affiliated research associate located at Stanford’s Hopkins Marine Station. “They can synergize with local efforts in the developing world to fight parasitic disease and to foster new aquaculture-based industries.” Thus, the approach could bring four major benefits: disease control, biodiversity restoration, poverty alleviation, and improved nutrition.
Why a drug can’t do it alone
The stakes are high. Worldwide, nearly 800 million people are at risk of getting schistosomiasis—most colloquially known as “blood flukes”—an infestation of parasitic flatworms which can cause anemia, growth-stunting, infertility, liver failure, bladder cancer, and lasting cognitive impairment.
Currently, the only treatment for the disease is the drug praziquantel. Insufficient global supplies, cost, and other factors limit that drug’s effectiveness. Even if it were widely and cheaply available, praziquantel would be an incomplete solution for people who enter river water to bathe and clean clothing, among other reasons, and get reinfected frequently through contact with schistosome-contaminated waters.
In Africa, where most schistosomiasis cases occur, rates of infection often increased dramatically after construction of big dams. De Leo and his fellow researchers speculate this is due not only to the dams’ positive impact on snail habitat but to the dams’ negative impact on snail predators, including freshwater prawns, that need to travel upstream and downstream to mate and lay eggs.
In addition to stocking river access points, the researchers suggest prawns could be restored to rivers through the use of dam-bypassing passages similar to salmon ladders used in the Western United States.
The Bill & Melinda Gates Foundation, the National Institutes of Health, the National Science Foundation, Grand Challenges Canada, and Environmental Venture Projects, a seed grant program via Stanford, have funded the work.
The researchers plan to expand their work to focus on a range of natural solutions to global health and poverty challenges as part of an initiative called the Upstream Alliance. While the prawn research has shown the effectiveness of natural solutions at small scales, the researchers plan to explore whether such approaches can be viable and sustainable on larger scales.
Coauthors of the paper include researchers from the 20/20 Initiative; University of California, Santa Barbara; the Institut Pasteur de Lille, France; and the Biomedical Research Center Espoir pour la Santé, Saint-Louis, Senegal.
Source: Stanford University